$VTGN News Article - VistaGen Therapeutics Receive
Post# of 130
(Total Views: 382)
Posted On: 01/30/2020 10:35:41 AM
$VTGN News Article - VistaGen Therapeutics Receives FDA Clearance of IND for Phase 2 Clinical Study of AV-101 as a Potential Treatment of Dyskinesia in Parkinson's Disease Patients https://marketwirenews.com/news-releases/vist...03152.html
(0)
(0)VistaGen Therapeutics, Inc. (VTGN) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼